37 min
Molecular therapeutics: how far have we come and what is on the horizon? Future Science Group
-
- Science
Uncover the history of molecular therapeutics, the staggering current applications and developments of these therapeutics and what their future could hold, in this episode of Talking Techniques.
To explore the field of molecular therapeutics and provide an insight into their production, is Aaron Clauson, Product Manager at Zymo research. First, we cover the ins and outs of targeting the therapies and how to select the correct type of molecular therapeutic to begin developing a drug for a specific disease, before looking at some of the setbacks and safety errors that have occurred during the development of molecular therapeutics and how researchers have learned from these tragic events.
Aaron also highlights the vital role of plasmids in almost all molecular therapeutic development, detailing the importance of keeping plasmid solutions and transfections free of endotoxins, revealing key solutions for avoiding these contaminants.
Listen today to get all you need to know about molecular therapeutics, from their inception to their most exciting examples and how we can better communicate their benefits to the public in order to avoid mistrust and confusion - as has occurred during the COVID-19 pandemic.
Contents:What counts as a molecular therapeutic? 01:45-02:40Well known molecular therapeutics 02:40-05:00What can molecular therapeutics achieve that synthetic chemicals can’t? 05:00-05:55Targeting molecular therapeutics and picking the right type of therapeutic 05:55-08:25Selecting the appropriate molecular therapeutic 08:35-11:00Setbacks and safety concerns in gene therapies 11:00-15:45Preventing off-target effects in gene therapies 15:45-17:35Challenges in the development of molecular therapeutics 17:35-19:05 Plasmids in molecular therapeutic development 19:05-23:55 Avoiding endotoxins: 23:55-27:45What fields do you find most exciting? 27:45-28:50Better communication of gene therapies to the public 28:50-32:00 “security agencies detecting molecular therapeutics” 29:10Improving molecular therapeutic development: 32:00-37:10
Uncover the history of molecular therapeutics, the staggering current applications and developments of these therapeutics and what their future could hold, in this episode of Talking Techniques.
To explore the field of molecular therapeutics and provide an insight into their production, is Aaron Clauson, Product Manager at Zymo research. First, we cover the ins and outs of targeting the therapies and how to select the correct type of molecular therapeutic to begin developing a drug for a specific disease, before looking at some of the setbacks and safety errors that have occurred during the development of molecular therapeutics and how researchers have learned from these tragic events.
Aaron also highlights the vital role of plasmids in almost all molecular therapeutic development, detailing the importance of keeping plasmid solutions and transfections free of endotoxins, revealing key solutions for avoiding these contaminants.
Listen today to get all you need to know about molecular therapeutics, from their inception to their most exciting examples and how we can better communicate their benefits to the public in order to avoid mistrust and confusion - as has occurred during the COVID-19 pandemic.
Contents:What counts as a molecular therapeutic? 01:45-02:40Well known molecular therapeutics 02:40-05:00What can molecular therapeutics achieve that synthetic chemicals can’t? 05:00-05:55Targeting molecular therapeutics and picking the right type of therapeutic 05:55-08:25Selecting the appropriate molecular therapeutic 08:35-11:00Setbacks and safety concerns in gene therapies 11:00-15:45Preventing off-target effects in gene therapies 15:45-17:35Challenges in the development of molecular therapeutics 17:35-19:05 Plasmids in molecular therapeutic development 19:05-23:55 Avoiding endotoxins: 23:55-27:45What fields do you find most exciting? 27:45-28:50Better communication of gene therapies to the public 28:50-32:00 “security agencies detecting molecular therapeutics” 29:10Improving molecular therapeutic development: 32:00-37:10
37 min
Top Podcasts In Science